MENU
+Compare
LAB
Stock ticker: NASDAQ
AS OF
Jul 1, 04:39 PM (EDT)
Price
$1.29
Change
+$0.09 (+7.50%)
Capitalization
1.04B

LAB Standard BioTools Forecast, Technical & Fundamental Analysis

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more

LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LAB with price predictions
Jun 30, 2025

LAB in upward trend: price rose above 50-day moving average on June 23, 2025

LAB moved above its 50-day moving average on June 23, 2025 date and that indicates a change from a downward trend to an upward trend. In of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 18, 2025. You may want to consider a long position or call options on LAB as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LAB just turned positive on June 02, 2025. Looking at past instances where LAB's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for LAB crossed bullishly above the 50-day moving average on June 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LAB advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 137 cases where LAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where LAB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

LAB broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.869) is normal, around the industry mean (24.307). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.010) is also within normal values, averaging (42.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LAB is expected to report earnings to fall 4.71% to -6 cents per share on August 06

Standard BioTools LAB Stock Earnings Reports
Q2'25
Est.
$-0.07
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
The last earnings report on May 06 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 785.60K shares outstanding, the current market capitalization sits at 1.04B.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated fluidic circuit systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2 Tower Place
Phone
+1 650 266-6000
Employees
539
Web
https://www.standardbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIESX20.86N/A
N/A
Franklin International Equity IS
NBGTX30.82N/A
N/A
Neuberger Berman Large Cap Growth Tr
HDGCX33.01N/A
N/A
Hartford Dividend and Growth C
MIGIX19.77N/A
N/A
Morgan Stanley Inst Global Insgt I
FNGRX18.17N/A
N/A
Franklin Intl Growth R

LAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with CERS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
+0.84%
CERS - LAB
53%
Loosely correlated
-0.70%
PACB - LAB
46%
Loosely correlated
-3.88%
ATEC - LAB
45%
Loosely correlated
+0.18%
TMCI - LAB
45%
Loosely correlated
+2.26%
RVTY - LAB
43%
Loosely correlated
-1.12%
More